Dr Daniel Krell, Consultant Oncologist
Dr Daniel Krell
Consultant Oncologist
Dr Daniel Krell MBChB BSc MRCP Dphil
Consultant Oncologist
Dr Daniel Krell
Consultant Oncologist MBChB BSc MRCP Dphil
Areas of expertise
- Chemotherapy
- Genetic testing
- Biological therapy
- Clinical trials
- Immunotherapy
Recommendations for Dr Krell
These recommendations are for information purposes only. Doctors providing recommendations do so in good faith and are not responsible for clinical outcomes.
Recommended by:
Make an appointment
Address
-
The Harley Street Clinic
35 Weymouth St, London, W1G 8BJ
-
LOC at Chelsea
102 Sydney Street, Chelsea
-
Platinum Medical Centre
15-17, Lodge Road, London, NW8 7JA
-
The Wellington Hospital
St Johns Wood, London, NW8 7JA
-
Video consultation
Online
-
LOC - Leaders in Oncology Care
95 Harley Street, London, W1G 6AF
About Dr Daniel Krell
GMC number: 6075167
Year qualified: 2003
Place of primary qualification: University of Leeds
Dr Daniel Krell is a consultant oncologist at the Royal Free Trust, specialising in gastro-oesophageal, colorectal, pancreatic, liver, and bile duct cancers, as well as neuroendocrine tumours. He is highly experienced in administering chemotherapy, targeted therapy, and immunotherapy. Dr Krell also manages patients with cancer of unknown primary and serves as the clinical lead for this area.
Dr Krell is an integral member of the multidisciplinary team for gastro-oesophageal and hepatobiliary cancer at the Royal Free Trust. Additionally, he holds the position of clinical lead for neuroendocrine tumour oncology at The Royal Free Hospital.
Dr Krell completed his oncology training at University College and the Royal Free Hospitals in London. He holds a primary medical degree, a Bachelor’s degree in immunology and microbiology, and a DPhil in Clinical Medicine from the University of Oxford’s Wellcome Trust Centre for Human Genetics. His research, funded by Cancer Research UK and HCA, focused on the role of genetic mutations in genes controlling cellular metabolism in cancer development, potentially identifying new therapeutic targets.
Dr Krell remains actively involved in clinical research and trials aimed at discovering new cancer therapies, particularly for gastrointestinal, hepatobiliary, and neuroendocrine tumours. He has published numerous peer-reviewed papers and has presented his findings at both national and international conferences.
He treats a variety of conditions, including:
- Liver cancer
- Biliary cancer
- Bowel cancer
- Colorectal cancer
- Oesophageal cancer
- Pancreatic cancer
Dr Krell has been serving in his current roles since his appointment, bringing a wealth of knowledge and dedication to his patients and the medical community.
Areas of expertise
- Acute oncology
- Adenocarcinoma
- Bilary cancer
- Bile duct cancer (cholangiocarcinoma)
- Biological therapy
- Bowel cancer
- Cancer of unknown primary
- Chemotherapy
- Cholangiocarcinoma
- Clinical trials
- Colon cancer
- Colorectal cancer
- Gallbladder cancer
- Gastric cancer
- Gastrointestinal cancers
- Gastrointestinal stromal tumour (GIST)
- Gastro-oesophageal cancer
- Genetic testing
- Hepatocellular carcinoma
- Immunotherapy
- Liver cancer
- Molecular genetic profiling
- Neoadjuvant
- Neuroendocrine cancer
- Neuroendocrine tumours (NETS)
- Oesophageal cancer
- Pancreatic and biliary tract cancer
- Rectal cancer
- Small bowel cancer
- Targeted therapy